Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Lisata Therapeutics News

Aktie
WKN:  A3DWGC ISIN:  US1280583022 US-Symbol:  LSTA Branche:  Biotechnologie Land:  USA
3,23 $
-0,14 $
-4,15%
2,7457 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
14,04 Mio. €
Streubesitz
71,94%
KGV
-0,92
Index-Zuordnung
-

Lisata Therapeutics News

09.03.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
11.02.26 - PR Newswire
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders? PR Newswire
11.02.26 - PR Newswire
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders? PR Newswire
28.01.26 - PR Newswire
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
28.01.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA PR Newswire
17.11.25 - EQS
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Original-​Research: Lisata Therapeutics Inc - from First Berlin Equity Research GmbH 17.11.2025 / 15:19 CET/CEST Dissemination of a Research, transmitted by EQS News - a ...
18.08.25 - EQS
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Original-​Research: Lisata Therapeutics Inc - from First Berlin Equity Research GmbH 18.08.2025 / 13:41 CET/CEST Dissemination of a Research, transmitted by EQS News - a ...
15.08.23 - PR Newswire
Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers
Impilo Therapeutics Launches to Enable Nucleic Acid-​Based Medicines to Effectively Treat Solid Tumor Cancers PR Newswire
04.08.22 - PR Newswire
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates PING, CLBS, MANT
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates PING, CLBS, MANT PR Newswire
03.05.22 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MCAF, FRLA, CLBS, IGNY
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MCAF, FRLA, CLBS, IGNY PR Newswire
28.04.22 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, CLBS, ISLE, AOGO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, CLBS, ISLE, AOGO PR Newswire
27.04.22 - PR Newswire
Thinking about buying stock in Vivakor, Cyngn, Evoke Pharma, Lucid Group, or Caladrius Biosciences?
Thinking about buying stock in Vivakor, Cyngn, Evoke Pharma, Lucid Group, or Caladrius Biosciences? PR Newswire
05.01.22 - PR Newswire
Thinking about buying stock in Lixte Biotechnology, Data Storage, Castlight Health, Cleveland-Cliffs, or Caladrius Biosciences?
Thinking about buying stock in Lixte Biotechnology, Data Storage, Castlight Health, Cleveland-​Cliffs, or Caladrius Biosciences? PR Newswire
20.01.21 - PR Newswire
Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp?
Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp? PR Newswire
14.06.17 - PR Newswire
Invetech and Caladrius Biosciences Receive 2017 Good Design Award® for Design of a Counterflow Centrifuge Device for use in the Development of Cell Therapies
Invetech and Caladrius Biosciences Receive 2017 Good Design Award® for Design of a Counterflow Centrifuge Device for use in the Development of Cell Therapies Breakthrough ...
10.04.17 - PR Newswire
Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Caladrius Biosciences, Inc. - CLBS
Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Caladrius Biosciences, Inc. - CLBS PR Newswire
06.11.12 - PR Newswire
NYSE, Toronto TSX and OTC Markets Companies Webcast Live to Investors on November 8th at RetailInvestorConferences.com
NYSE, Toronto TSX and OTC Markets Companies Webcast Live to Investors on November 8th at RetailInvestorConferences.com CEOs to take questions in real-time during formal ...
01.10.12 - PR Newswire
NYSE, NASDAQ, OTC Markets and TSX Companies Join to Webcast Live to Investors: October 4th at RetailInvestorConferences.com
NYSE, NASDAQ, OTC Markets and TSX Companies Join to Webcast Live to Investors: October 4th at RetailInvestorConferences.com CEOs to take questions in real-time during ...
23.08.11 - Aktiencheck
NeoStem leicht rückläufiger Umsatz - Hot Stocks Investor
Die Experten von "Hot Stocks Investor" empfehlen Anlegern, die noch vor 14 Tagen gezögert haben, bei der Aktie der NeoStem Inc. mit ein paar Stücken aufzuspringen. Zunächst ...

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »